Ultrasonic Assessment of Myocardial Microstructure
January 14th, 2014
5.3K views
Echocardiography is commonly used to noninvasively characterize and quantify changes in cardiac structure and function. We describe an ultrasound-based imaging algorithm that offers an enhanced surrogate measure of myocardial microstructure and can be performed using open-access image analysis software.
Overview
This article presents an ultrasound-based imaging algorithm designed to provide a surrogate measure of myocardial microstructure. The method utilizes open-access image analysis software to enhance the characterization of cardiac structure and function.
Key Study Components
Area of Science
- Cardiology
- Medical Imaging
- Ultrasound Technology
Background
- Echocardiography is a noninvasive technique for assessing cardiac health.
- Myocardial microstructure is crucial for understanding heart function.
- Existing methods may not provide detailed insights into myocardial density.
- Open-access software facilitates broader use of advanced imaging techniques.
Purpose of Study
- To develop an imaging algorithm for better assessment of myocardial microstructure.
- To utilize open-access software for processing echocardiographic images.
- To establish a method for calculating myocardial to pericardial ratios.
Methods Used
- Selection and formatting of digital echocardiographic images.
- Identification of myocardial regions of interest and pericardial reference areas.
- Application of the imaging algorithm using Image J software.
- Calculation of myocardial density and ratios for analysis.
Main Results
- The algorithm successfully processes echocardiographic signals.
- Output includes myocardial to pericardial ratios indicative of microstructure.
- Results provide insights into myocardial density and tissue characteristics.
- The method is reproducible and accessible for further research.
Conclusions
- The ultrasound-based imaging algorithm enhances myocardial assessment.
- Open-access software promotes wider adoption of advanced imaging techniques.
- This approach offers a valuable tool for researchers in cardiac health.
Frequently Asked Questions
What is the main advantage of this imaging algorithm?
The algorithm provides a detailed surrogate measure of myocardial microstructure using noninvasive echocardiography.
How does the open-access software contribute to this study?
It allows researchers to easily process and analyze echocardiographic images without proprietary software costs.
What are myocardial to pericardial ratios?
These ratios are calculated to assess myocardial density relative to the pericardial area, providing insights into tissue microstructure.
Can this method be used in clinical settings?
Yes, the noninvasive nature and accessibility of the software make it suitable for clinical applications.
What is the significance of myocardial microstructure?
Understanding myocardial microstructure is essential for diagnosing and treating various cardiac conditions.
Is prior experience with echocardiography necessary?
While helpful, the method is designed to be user-friendly for researchers with varying levels of experience.
Executive Industry Relevance
This ultrasound-based algorithm provides a surrogate measure of myocardial microstructure, enabling enhanced characterization of cardiac tissue beyond macroscopic parameters. By leveraging open-access image analysis software, the method supports reproducible, quantitative assessment of myocardial density and tissue microstructure in preclinical models. The approach offers translational value for target validation and mechanistic de-risking in cardiovascular drug discovery pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by quantifying myocardial microstructure changes in disease models.
- Operational Value: Supports biological de-risking through objective, surrogate measures of tissue remodeling and fibrosis.
- Predictive Value: Enhances confidence in target engagement by linking molecular interventions to quantifiable tissue-level outcomes.
Screening & Assay Development
- Assay Readiness: Prepares validated biological systems for downstream workflows by establishing standardized myocardial-to-pericardial intensity ratios.
- Quantitative Output: Delivers reproducible, distribution-based signal intensity metrics (20th, 50th, 80th percentiles) for compound screening.
- Platform Reuse: Enables scalable, open-source-based analysis across mouse and human echocardiographic datasets.
Translational & Preclinical Research
- Disease Relevance: Distinguishes between control and chronic afterload-stressed states in mouse and human models, supporting pathophysiological modeling.
- Translational Continuity: Bridges discovery and preclinical validation through consistent microstructure assessment across species.
- Risk-Adjusted Advancement: Informs go/no-go decisions by providing quantitative biomarkers of tissue-level drug effects.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from early target validation through preclinical assessment, supporting hypothesis-driven evaluation of cardiovascular therapeutics.
- Discovery Biology: Facilitates hypothesis testing and pathway clarification by quantifying microstructural alterations in myocardial tissue.
- Screening: Ensures assay readiness and reproducibility through standardized region-of-interest selection and histogram-based intensity analysis.
- Analytics: Generates quantitative myocardial-to-pericardial ratios at multiple percentiles, enabling comparative analysis across experimental conditions.
- Translational Research: Supports preclinical continuity by applying identical analytical frameworks to mouse and human imaging data.
- Enterprise Reuse: Leverages open-access Image J software to promote cross-team standardization and platform scalability.
Operational & Enterprise Impact
- Scientific Value: Provides predictive confidence in target validation through surrogate microstructure measurement.
- Operational Value: Ensures standardization and reproducibility via protocolized ROI selection and histogram macro execution.
- Strategic Value: Improves go/no-go decisions by reducing mechanistic ambiguity in cardiovascular disease models.
- Portfolio Impact: Enables risk-adjusted prioritization based on quantitative tissue-level responses to intervention.
Implementation Considerations
- Requires expertise in echocardiographic image acquisition and region-of-interest delineation.
- Dependent on Image J software and histogram macro installation for signal intensity analysis.
- Necessitates standardized training for consistent myocardial and pericardial ROI placement across users.
- Limited by image quality requirements, including sufficient resolution to demarcate myocardial and pericardial borders.
- Relies on end-diastolic frame selection guided by ECG tracing, adding procedural dependency on physiological gating.
Biopharma FAQs
Why does ratio of 80th percentile values matter for target validation?
The ratio of 80th percentile myocardial to pericardial signal intensity demonstrates the greatest difference between control and afterload-stressed cases, providing a sensitive surrogate for myocardial microstructure changes relevant to target engagement.
How does isolating myocardial and pericardial regions of interest fit the discovery pipeline?
Selecting standardized myocardial and pericardial regions of interest enables reproducible quantification of tissue-specific signal intensity, supporting hypothesis testing and biological de-risking in early discovery.
What do quantitative myocardial-to-pericardial ratio measurements enable?
These ratios provide a normalized, quantitative surrogate of myocardial density and microstructure, allowing comparison across experimental conditions and disease states.
Why do replication requirements matter for cross-functional collaboration?
Replication ensures consistent histogram-derived percentile values across users and studies, supporting standardization and reliable data sharing between discovery and preclinical teams.
What statistical analysis capabilities are required before implementation?
Implementation requires the ability to generate and analyze signal intensity histograms, including calculation of 20th, 50th, and 80th percentile values using the Image J histogram macro.
Chapters in this video
0:05
Title
1:35
Preparation of Images and Analyses
2:53
ROI Sampling: Pericardial Reference Selection
4:30
Generating a Histogram of Intensity Values Using ImageJ Histogram Macro
5:26
ROI Sampling: Myocardial Selection
6:48
Data Analysis and Processing
7:48
Results: Signal Intensity Changes During the Cardiac Cycle and with Afterload Stress
10:32
Conclusion
